Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/16433Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Gupta, Ranju | - |
| dc.contributor.author | Jindal, Dharam Paul | - |
| dc.contributor.author | Borras, M | - |
| dc.contributor.author | Legros, N | - |
| dc.contributor.author | Leclercq, G | - |
| dc.date.accessioned | 2013-03-23T12:45:23Z | - |
| dc.date.available | 2013-03-23T12:45:23Z | - |
| dc.date.issued | 1999-05 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/16433 | - |
| dc.description | 563-571 | en_US |
| dc.description.abstract | 3-Methoxy-17-aza-D-homo-1,3,5(10)-estratrienc-16, 17a-dione 3, 16, 17a-dioxo-17-aza-D-homo-1,3,5(10)-estratrien-3-yl acctate 12 and a series of related compounds have been synthesised from 3-methoxy-16-oximino- 1,3,5 (10)-estrairian-17- one 1 and 3-hydroxy-16-oximino- 1,3,5 (10)-estnttrien-17-one 2, respectively. The compounds 3 (DPJ-280), 14 (DPJ-369), 17 (DPJ-370), 18 (DPJ-354), 19 (DPJ-320), 21 (DPJ- 321 ), 22 (DPJ-374) and (DPJ-284) have been evaluated for their estrogenic/antiestrogenic effects and the compounds 3-7,8,9,10,12,15,16,18,20,21,23 and 24 have been screened for antineoplastic activity at NCI, Bethesda. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | NISCAIR-CSIR, India | en_US |
| dc.rights |  CC Attribution-Noncommercial-No Derivative Works 2.5 India | en_US |
| dc.source | IJC-B Vol.38B(05) [May 1999] | en_US |
| dc.title | Synthesis and biological activity of some D-ring modified estrone derivatives | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | IJC-B Vol.38B(05) [May 1999] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJCB 38B(5) 563-571.pdf | 2.27 MB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.